Heart Tronics (HRTT) Stock Price

Heart Tronics Price

OTC·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Heart Tronics stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Heart Tronics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Heart Tronics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Heart Tronics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Heart Tronics Stock Price History
DateHeart Tronics Price
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
8/8/20250.00 USD
8/7/20250.00 USD
8/6/20250.00 USD
8/5/20250.00 USD
8/4/20250.00 USD
8/1/20250.00 USD
7/31/20250.00 USD
7/30/20250.00 USD
7/29/20250.00 USD
7/28/20250.00 USD
7/25/20250.00 USD
Access this data via the Eulerpool API

Heart Tronics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2000
0.00 USD
-30,000.00 USD
-30,000.00 USD
Jan 1, 2001
0.00 USD
-80,000.00 USD
-80,000.00 USD
Jan 1, 2002
0.00 USD
-212,000.00 USD
-212,000.00 USD
Jan 1, 2003
0.00 USD
-5.32 M USD
-7.26 M USD
Jan 1, 2004
0.00 USD
-6.72 M USD
-7.26 M USD
Jan 1, 2005
0.00 USD
-7.55 M USD
-8.72 M USD
Jan 1, 2006
190,000.00 USD
-13.35 M USD
-11.75 M USD
Jan 1, 2007
0.00 USD
-14.46 M USD
-13.91 M USD

Heart Tronics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 24, 2026, 10:16 PM
 
EBITM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESk
20002001200220032004200520062007
-5.00-6.00-7.00-13.00-14.00
-7.00-7.00-8.00-11.00-13.00
14.2937.5018.18
10.6010.602.607.007.408.208.7010.60
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Heart Tronics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Heart Tronics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Heart Tronics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Heart Tronics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Heart Tronics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Heart Tronics stock margins

The Heart Tronics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Heart Tronics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Heart Tronics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2000
77.89 %
- %
- %
Jan 1, 2001
77.89 %
- %
- %
Jan 1, 2002
77.89 %
- %
- %
Jan 1, 2003
77.89 %
- %
- %
Jan 1, 2004
77.89 %
- %
- %
Jan 1, 2005
77.89 %
- %
- %
Jan 1, 2006
77.89 %
-7,028.42 %
-6,184.21 %
Jan 1, 2007
77.89 %
- %
- %

Heart Tronics Stock Revenue, EBIT, Earnings per Share

The Heart Tronics earnings per share therefore indicates how much revenue Heart Tronics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2000
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2001
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2002
0.00 USD
-81.54 USD
-81.54 USD
Jan 1, 2003
0.00 USD
-759.43 USD
-1,037.71 USD
Jan 1, 2004
0.00 USD
-907.57 USD
-981.08 USD
Jan 1, 2005
0.00 USD
-920.98 USD
-1,062.80 USD
Jan 1, 2006
21.84 USD
-1,534.94 USD
-1,350.57 USD
Jan 1, 2007
0.00 USD
-1,364.15 USD
-1,312.45 USD

Heart Tronics business model & stock analysis

Heart Tronics Inc. is a company specializing in the development of medical devices and technologies aimed at monitoring and treating heart diseases. It was founded in 2000 by Dr. A. Martin Gerdes and is headquartered in Irvine, California. The company's business model is based on the development, production, and sale of life-saving medical devices. They offer a wide range of diagnostic and monitoring devices that help doctors diagnose and treat heart diseases. One of their main focuses is the development of devices for monitoring heart rhythm disorders, including factors like blood pressure, pulse rate, and respiratory rate. They also develop devices for the treatment of heart diseases, such as electrophysiological (EP) ablation devices and implantable cardioverter-defibrillators (ICD). Additionally, they have developed telemedicine products for remote patient monitoring, allowing doctors to monitor and analyze patient data in real time. Overall, Heart Tronics has developed a variety of products that have proven effective in the medical community and are focused on saving lives by helping doctors detect diseases and take preventive measures. The company is well positioned for future growth due to advancements in telemedicine and medical devices. They plan to expand their portfolio to develop even more life-saving technologies in the future. In conclusion, Heart Tronics is a company driven by the clear goal of saving lives. They have established themselves as pioneers in the development of medical devices for the treatment of heart diseases and are committed to continuously developing innovative technologies to improve people's lives.

Heart Tronics SWOT Analysis

Strengths

Heart Tronics Inc has several strengths that contribute to its success in the market:

  • Strong market presence and brand recognition
  • Advanced technology and innovative product offerings
  • Highly skilled and experienced team of researchers and engineers
  • Robust distribution network ensuring wide market reach
  • Strong financial position and steady revenue growth

Weaknesses

Despite its strengths, Heart Tronics Inc also faces some weaknesses that need to be addressed:

  • Relatively limited product portfolio compared to competitors
  • Dependence on a few key customers for a significant portion of its sales
  • Slow response to emerging market trends and customer demands
  • High production costs leading to lower profit margins
  • Need for improved supply chain management to reduce lead times

Opportunities

Heart Tronics Inc should explore the following opportunities to drive future growth:

  • Expanding product line to cater to a broader range of customer needs
  • Entering new geographical markets with emerging healthcare sectors
  • Collaborating with healthcare providers and institutions for joint R&D projects
  • Investing in research and development to introduce breakthrough technologies
  • Capitalizing on increasing global demand for medical devices

Threats

Heart Tronics Inc should be aware of the following threats that may pose challenges:

  • Intense competition from established medical device companies
  • Stringent regulatory environment for medical device approvals
  • Potential disruptions in supply chain due to global economic factors
  • Rapidly changing industry dynamics and technological advancements
  • Vulnerability to lawsuits related to product safety or efficacy

Heart Tronics Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Heart Tronics historical P/E ratio, EBIT multiple, and P/S ratio

Heart Tronics annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Heart Tronics shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2000
10,600.00 Stocks
Jan 1, 2001
10,600.00 Stocks
Jan 1, 2002
2,600.00 Stocks
Jan 1, 2003
7,000.00 Stocks
Jan 1, 2004
7,400.00 Stocks
Jan 1, 2005
8,200.00 Stocks
Jan 1, 2006
8,700.00 Stocks
Jan 1, 2007
10,600.00 Stocks
Price targets and forecasts for Heart Tronics are not yet available.

Heart Tronics Executives and Management Board

WG

Willie Gault

President, Director · since 2008

RP

Rowland Perkins

(78)

Chief Executive Officer, Director · since 2005

JB

Ms. Jennifer Black

(59)

Director

RK

Dr. Robert Koblin

(81)

Director

Frequently asked questions about Heart Tronics

Heart Tronics Inc operates in the medical device industry. The company specializes in developing and manufacturing innovative and advanced cardiovascular monitoring systems. Their business model revolves around providing healthcare professionals with cutting-edge technologies to improve patient care and outcomes. Heart Tronics Inc aims to deliver reliable and user-friendly monitoring devices, ensuring accurate and real-time data collection for the diagnosis and treatment of cardiovascular diseases. By prioritizing product innovation and quality, Heart Tronics Inc strives to remain a leading player in the medical device sector, dedicated to enhancing cardiac healthcare worldwide.

All fundamentals and in-depth analysis of Heart Tronics

Our stock analysis for Heart Tronics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Heart Tronics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.